"The idea of a British dermatology clinical trials network is about doing something collectively on a grand scale that could begin to change the face of dermatology clinical trials" Professor Hywel Williams, Network Chair
Dermatology Research: Do you have an unanswered clinical question?
The UK Dermatology Clinical Trials Network collects unanswered questions on skin disease treatments. If you have a research idea then, with our help, you could develop your idea into a clinical trial. Go to the 'Submit a trial idea' page to find out more.
CLOTHES Study on target
This study looking at specialist clothing for children with moderate to severe eczema, has recruited 150 patients! This is fantastic news as it mean the study is already half way to its recruitment target of 300 participants. For more details of the study please see the University of Nottingham website.
CREAM Study adopted onto UKDCTN portfolio
We are delighted to join forces with the CREAM study team who are running a study on treating infected eczema in children. The Chief investigator is Dr Nick Francis (Cardiff) and the study is run from the South East Wales Trials Unit. The main aim is to assess whether oral or topical antibiotic treatment (in addition to treatment with corticosteroid cream) reduces subjective eczema severity in children with suspected infected eczema. Please visit the CREAM study website for more information or contact Victoria Shepard email email@example.com
UK DCTN Fellowship Awards 2015
Once again we are offering five awards to those interested in dermatology research. If you are a dermatology SpR, nurse, SAS (staff grade) doctor or GP then you could qualify for a £1,500 award to take part in training on applied dermatology research. Apply now - deadline for applications is 31 October 2014. Contact Carron Layfield for more information or look at our award pages here.
Acne Priority setting Partnership - Top Ten research questions
The priority setting exercise looking for the most important questions for research into acne is complete! The top ten questions, decided by both patients and health professionals, is now available to view on the Acne PSP website. The questions will be picked up by researchers and funders and it is hoped the studies generated from this valuable exercise will eventually lead to improving treatments for acne.
Hidradenitis Suppurativa (HS) Priority Setting Partnership (PSP)
Many thanks to everyone who took part in our hidradenitis suppurativa surveys, we had a fantastic response from both patients and health professionals.
The uncertainties (research questions) were collated into 55 potential priorities and then you voted for your top 10 in survey two. We took 30 of the most popular questions to a workshop with representatives from patient groups, dermatology, nursing, surgery and primary care. Together we agreed, after much discussion and debate, a top 10. It is hoped these questions will be submitted to funding bodies in the future for more research into HS and at the same time raise the profile of this distressing, painful but little known disease. More information on this exercise can be found on our research prioritisation pages or see the top ten here.
10 Dec 2013
CLOTHES Trial open to recruitment
We are pleased to announce that the much anticipated Clothes study (Clothing for the relief of eczema symptoms in children) is open to recruitment in Nottingham. Other recruiting sites will soon follow in London, Cambridge, Portsmouth and Isle of Wight. See the website here for more information.
8 Nov 2013
Poster prize for UKDCTN Clinical Trial
Jo Perdue, clinical trial research assistant for the PATCH studies, won the poster prize at the Trial Manager’s Network meeting this month. She was the resounding winner for a clear and informative poster on publicising a study to successfully improve patient recruitment to the PATCH I study. You can view the poster here.
PATCH I Cellulitis Results - Low dose penicillin cuts recurrence of cellulitis
We are very pleased to announce the results of the PATCH I cellulitis trial, published here by the New England Journal of Medicine. For more details of our PATCH studies please see the completed trials page.
2 May 2013